Publications
& Policy

The importance of venture capital in the EU’s life science industry.

Invest Europe replied to the BEFIT public consultation. In this document Invest Europe supports the main objectives of BEFIT as set out in the Call for Evidence, but in addition recognises the need for further clarifications due to the high-level description of the BEFIT rules.

Altogether 33 Finnish general partners of venture capital and private equity funds responded to the questionnaire. This represents some 90% of the players, almost the entire market.

Exploring Europe's deep tech credentials, hurdles and opportunities.

In this response, we share our views on the possible features and risks of greenwashing in the financial services sector. Among others, we note that the complexity, lack of clarity around key concepts and moving goalposts with each iteration of guidance/Q&As under the current SFDR regime are a major source of greenwashing risk.

In this response Invest Europe comments on the inadequacy of the concept of a "single undertaking" which does not sufficiently take into consideration the nature of private equity investments, at the risk of making it harder for private equity-backed businesses to receive financial support from the state.

Ecares: The entry of private equity investors into the healthcare sector may lead to negative impacts on coverage, pricing, and quality, due to the margin for cream-skimming allowed to these firms to ease their entry in the sector.

The majority of GPs have already integrated ESG considerations into their investment process.

Institutional Investor: It is hard to value private assets such as private equity, venture capital, and real estate investments.

During this Members' Policy Call, Invest Europe members were given an in-depth presentation of the InvestEU Programme by the European Investment Fund (EIF).

The definitive, data-led report for the European tech ecosystem.

This Handbook has been developed as a user-friendly overview of EU funding opportunities intended to bridge the information gap for our members, linking innovators with the public bodies mandated to support them. This document lays out the multiple EU funding opportunities that exist, both for fund managers and for the portfolio companies they invest into. It covers financing in areas as wide as innovation, transport, energy, healthcare and life sciences, and cohesion.

The fundamental differences between trade group and private equity ownership models.